Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| JPMorgan Chase | 2.74% | $3.64M | $828.34B | 10.57% | 72 Outperform | |
| Enterprise Products Partners | 2.74% | $3.64M | $79.50B | 7.31% | 73 Outperform | |
| ASML Holding | 2.55% | $3.39M | $540.24B | 97.20% | 81 Outperform | |
| Novartis | 2.52% | $3.36M | $316.32B | 54.69% | 80 Outperform | |
| Morgan Stanley | 2.45% | $3.26M | $272.63B | 25.52% | 76 Outperform | |
| Exxon Mobil | 2.40% | $3.19M | $616.51B | 36.61% | 74 Outperform | |
| Merck & Company | 2.39% | $3.18M | $301.74B | 42.13% | 80 Outperform | |
| KLA | 2.36% | $3.14M | $192.71B | 91.07% | 77 Outperform | |
| Nexstar Media Group | 2.33% | $3.10M | $7.08B | 54.25% | 69 Neutral | |
| Broadcom | 2.29% | $3.04M | $1.58T | 45.81% | 76 Outperform |